ESC 365 - State of the Art - Genetic testing in dilated cardiomyopathy

ESC Premium Access

State of the Art - Genetic testing in dilated cardiomyopathy

Session: The potential of genetic testing in dilated cardiomyopathy

Topic: Valvular Heart Disease

Speaker: Professor C. Seidman (Boston, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Christine E Seidman

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 presentations

0 follower

4 more presentations in this session

Novel insights into desminopathy in the era of next generation sequencing

Speaker: Doctor M. Kubanek (Prague, CZ)

Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene.

Speaker: Doctor M. Akhtar (London, GB)

New risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies

Speaker: Doctor K. Wahbi (Paris, FR)

Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Speaker: Professor A. Bondue (Brussels, BE)

Access the full session

The potential of genetic testing in dilated cardiomyopathy

Speakers: Professor C. Seidman, Doctor M. Kubanek, Doctor M. Akhtar, Doctor K. Wahbi, Professor A. Bondue

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources